Genetic central nervous system malformation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:183506
Who is this for?
Show terms as
13Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic central nervous system (CNS) malformation is a broad grouping term used in Orphanet (ORPHA:183506) to classify a heterogeneous collection of rare congenital structural abnormalities of the brain and/or spinal cord that arise due to underlying genetic causes. These malformations result from disruptions in the complex processes of neural tube closure, neuronal proliferation, neuronal migration, cortical organization, or cerebellar and brainstem development. They encompass a wide spectrum of conditions including, but not limited to, holoprosencephaly, lissencephaly, polymicrogyria, schizencephaly, corpus callosum agenesis, cerebellar malformations, and various forms of neural tube defects with a genetic basis. Clinical features vary considerably depending on the specific malformation but commonly include intellectual disability, developmental delay, seizures or epilepsy, motor impairment (including spasticity and hypotonia), microcephaly or macrocephaly, and in some cases hydrocephalus. Cranial nerve dysfunction, visual impairment, and feeding difficulties may also be present. The severity ranges from mild learning difficulties to profound neurological disability incompatible with independent life. Because this is a classification category rather than a single disease entity, the underlying genetic causes are extremely diverse, involving numerous genes and inheritance patterns including autosomal dominant, autosomal recessive, X-linked, and de novo mutations. Treatment is largely supportive and symptomatic, including antiepileptic medications for seizure management, physical and occupational therapy, surgical interventions for hydrocephalus (such as ventriculoperitoneal shunting), and multidisciplinary rehabilitation. Genetic counseling is recommended for affected families. No curative therapies currently exist for most genetic CNS malformations.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Sep 2024Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome

Noema Pharma AG — PHASE2

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Genetic central nervous system malformation.

View clinical trials →

No actively recruiting trials found for Genetic central nervous system malformation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Genetic central nervous system malformation community →

Specialists

13 foundView all specialists →
TM
Tippi C MacKenzie, MD
San Francisco, California
Specialist

Rare Disease Specialist

PI on 2 active trials
PM
Prashant Chittiboina, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 7 active trials
MM
Marc Kamin, MD
OYSTER BAY, NY
Specialist
PI on 3 active trials
SP
Steven M Hersch, MD, PhD
BOSTON, MA
Specialist
PI on 2 active trials
HP
Huma Arshad Cheema, Prof.
Lahore, NY
Specialist

Rare Disease Specialist

PI on 1 active trial
MM
Michael H Bloch, MD, MS
Specialist
PI on 1 active trial
JN
James Neaton
Specialist
PI on 1 active trial1 Genetic central nervous system malformation publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Genetic central nervous system malformation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Genetic central nervous system malformationForum →

No community posts yet. Be the first to share your experience with Genetic central nervous system malformation.

Start the conversation →

Latest news about Genetic central nervous system malformation

No recent news articles for Genetic central nervous system malformation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Genetic central nervous system malformation

What is Genetic central nervous system malformation?

Genetic central nervous system (CNS) malformation is a broad grouping term used in Orphanet (ORPHA:183506) to classify a heterogeneous collection of rare congenital structural abnormalities of the brain and/or spinal cord that arise due to underlying genetic causes. These malformations result from disruptions in the complex processes of neural tube closure, neuronal proliferation, neuronal migration, cortical organization, or cerebellar and brainstem development. They encompass a wide spectrum of conditions including, but not limited to, holoprosencephaly, lissencephaly, polymicrogyria, schize

At what age does Genetic central nervous system malformation typically begin?

Typical onset of Genetic central nervous system malformation is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Genetic central nervous system malformation?

13 specialists and care centers treating Genetic central nervous system malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.